Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Review the VC funding altcoins list to identify which projects drew early and late stage VC support and what that implies for momentum.
9,919 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
June markets stay choppy as Aurora Innovation slides on Uber stake actions. This guide breaks down what it means for ...
The Federal Reserve’s annual stress tests show 32 large banks surviving a severe unemployment shock, with capital cus...
The spring 2026 Trustees Report shows social security’s trillion funding gap has grown to roughly $30 trillion, accel...
Space-based connectivity is drawing attention to AST SpaceMobile. This article analyzes potential price trajectories,...
A rare earth stock once-in-a-decade moment might be unfolding in the US with USA Rare Earth. This article breaks down...
Colorado House-approved measures to loosen lot-size rules stalled in the Senate, underscoring the heated battle over ...
Vitalik Buterin announced a recalibration of the Ethereum Foundation's role, underscoring a shift toward a smaller, p...
Amazon expands its AI funding spree, locking in another $17.5 billion in external financing as total external funding...
The BIS warns that AI-driven hype could trigger a stock-market pullback and spill into credit markets, threatening gl...
Inflation drives rising demand on food banks and affordable-housing providers as low-income families struggle with hi...
AAPD’s 3.43% yield looks appealing, but the bear-on-Apple fund relies on collateral interest instead of dividends. A ...